Avoiding bias in the prospective evaluation of patients with brain metastases [4]

Journal of Clinical Oncology

Volumn 25, Issue 25, 2007, Pages 4023-

  Vordermark, Dirk ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; CANCER SURVIVAL; COGNITION; HUMAN; KARNOFSKY PERFORMANCE STATUS; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE; BRAIN TUMOR; COGNITIVE DEFECT; EPIDEMIOLOGY; METASTASIS; NOTE; PROSPECTIVE STUDY; SKULL IRRADIATION;

BIAS (EPIDEMIOLOGY); BRAIN NEOPLASMS; COGNITION DISORDERS; CRANIAL IRRADIATION; HUMANS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 34548529214     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.4610     Document Type: Letter

References (3)

1. Li J, Bentzen SM, Renschier M, et al: Regression after whole-brain radiotherapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260-1266, 2007
2. Gaspar L, Scott C, Rotmann M, et al: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751, 1997
3. Addeo R, Caraglia M, Faiola V, et al: Concomitant treatment of brain metastasis with whole-brain radiotherapy (WBRT) and temozolomide (TMZ) is active and improves quality of life. BMC Cancer 7:18, 2007